Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells
Gabriel Duette, … , Timothy E. Schlub, Sarah Palmer
Gabriel Duette, … , Timothy E. Schlub, Sarah Palmer
Published February 8, 2022
Citation Information: J Clin Invest. 2022;132(7):e154422. https://doi.org/10.1172/JCI154422.
View: Text | PDF
Research Article AIDS/HIV Infectious disease Article has an altmetric score of 5

The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells

  • Text
  • PDF
Abstract

Despite long-term antiretroviral therapy (ART), HIV-1 persists within a reservoir of CD4+ T cells that contribute to viral rebound if treatment is interrupted. Identifying the cellular populations that contribute to the HIV-1 reservoir and understanding the mechanisms of viral persistence are necessary to achieve an effective cure. In this regard, through Full-Length Individual Proviral Sequencing, we observed that the HIV-1 proviral landscape was different and changed with time on ART across naive and memory CD4+ T cell subsets isolated from 24 participants. We found that the proportion of genetically intact HIV-1 proviruses was higher and persisted over time in effector memory CD4+ T cells when compared with naive, central, and transitional memory CD4+ T cells. Interestingly, we found that escape mutations remained stable over time within effector memory T cells during therapy. Finally, we provided evidence that Nef plays a role in the persistence of genetically intact HIV-1. These findings posit effector memory T cells as a key component of the HIV-1 reservoir and suggest Nef as an attractive therapeutic target.

Authors

Gabriel Duette, Bonnie Hiener, Hannah Morgan, Fernando G. Mazur, Vennila Mathivanan, Bethany A. Horsburgh, Katie Fisher, Orion Tong, Eunok Lee, Haelee Ahn, Ansari Shaik, Rémi Fromentin, Rebecca Hoh, Charline Bacchus-Souffan, Najla Nasr, Anthony L. Cunningham, Peter W. Hunt, Nicolas Chomont, Stuart G. Turville, Steven G. Deeks, Anthony D. Kelleher, Timothy E. Schlub, Sarah Palmer

×

Figure 10

Nef activity is higher in HIV-1–infected CD4+ Tem cells.

Options: View larger image (or click on image) Download as PowerPoint
Nef activity is higher in HIV-1–infected CD4+ Tem cells.
Memory CD4+ T c...
Memory CD4+ T cells from HIV-1– donors were sorted and infected with (A and B) HIV-BaL or (C–E) HIV-NL4-3-eGFP for 5 days. (A) Representative dot plots (top) and histograms (bottom) of 10 independent experiments showing CD4 geometric mean fluorescence intensity (gMFI) in uninfected p24– and HIV-1–infected p24+ cells. (B) CD4 expression in HIV-1–infected cells was calculated as CD4 gMFI in p24+ cells relative to CD4 gMFI in p24– cells. (C) Representative dot plots (top) and histograms (bottom) of 4 independent experiments showing HLA-A*02 gMFI in uninfected eGFP– and HIV-1–infected eGFP+ cells. (D) HLA-A*02 downmodulation in HIV-1–infected cells was calculated as HLA-A*02 gMFI in eGFP+ cells relative to HLA-A*02 gMFI in eGFP– cells. (E) eGFP MFI relative to Tcm values. Data represent the mean ± SD (B) or median ± 95% CI (D and E). One-way ANOVA followed by the (B) Tukey’s HSD post test or (D and E) Kruskal-Wallis followed by Dunn’s post test were performed to determine statistical significance. Each data point represents a single donor. Tcm, central memory; Ttm, transitional memory; Tem, effector memory. *P ≤ 0.05, **P ≤ 0.01.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 8 X users
On 2 Facebook pages
46 readers on Mendeley
See more details